2m 2m 2m 2m 2m 2m 2m
Q32 BIO (QTTB)
NASDAQ
$12.00-$0.64 (-5.06%)
Price as of Jun 03, 2026 6:02 PM EDT- $187.4MMarket Cap
- 558.33%1-Year Change
- BiotechnologyIndustry
Q32 BIO (QTTB)
$12.00-$0.64 (-5.06%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 53.7M N/A | 0 -100.00% | 1.2M -63.97% | 3.2M -90.56% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 53.7M N/A | 0 -100.00% | 1.2M -63.97% | 3.2M -90.56% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | 300,000 -57.14% | 700,000 N/A | |
Research and Development Expense | -19.2M -60.21% | -48.1M -22.35% | -62.0M -36.96% | -98.4M +5.66% | |
Depreciation and Amortization Expense | 391,000 -19.71% | 487,000 -15.74% | 578,000 -55.30% | 1.3M -84.52% | |
Total Operating Expenses | 36.8M -44.28% | 66.1M -35.56% | 102.6M -24.84% | 136.5M +5.06% | |
Operating Profit | 16.9M +125.57% | -66.1M -34.83% | -101.4M -23.90% | -133.3M +38.91% | |
Interest Income | N/A N/A | N/A N/A | 5.6M +72.82% | 3.2M +1,645.95% | |
Interest Expense | -1.1M 0.00% | -1.1M N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | -1.1M 0.00% | -1.1M -119.71% | 5.6M +72.82% | 3.2M +1,645.95% | |
Total Nonoperating Income and Expense | 12.9M -35.45% | 20.0M +39.49% | 14.3M -89.33% | 134.5M +72,591.35% | |
Income before Taxes | 29.8M +164.71% | -46.1M -47.08% | -87.1M -7,368.78% | 1.2M +101.25% | |
Income Taxes | 0 -100.00% | 21,000 N/A | 0 -100.00% | 715,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 29.8M +162.47% | -47.7M -57.74% | -113.0M +2,156.96% | -5.0M -94.77% | |
Net Income from Continuing Operations Applicable to Common | 29.8M +162.47% | -47.7M -45.18% | -87.1M -7,368.78% | 1.2M +101.25% | |
Basic EPS and Net Income | 2.42 +147.27% | -5.12 +162.56% | -1.95 +2,066.67% | -0.09 -94.80% | |
Diluted EPS and Net Income | 2.42 +136.78% | -6.58 +237.44% | -1.95 +2,066.67% | -0.09 -94.80% | |
Basic Weighted Average Shares | 12.3M +31.97% | 9.3M -83.88% | 57.8M +0.76% | 57.4M +3.83% | |
Diluted Weighted Average Shares | 12.3M +27.51% | 9.7M -83.30% | 57.8M +0.76% | 57.4M +3.83% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 48.3M -38.05% | 78.0M +98.56% | 39.3M +15.54% | 34.0M -68.64% | |
Short-Term Investments | 19.9M N/A | 0 -100.00% | 43.4M -69.24% | 141.0M +196.98% | |
Cash and Cash Equivalents and Short-Term Investments | 68.2M -12.52% | 78.0M -5.67% | 82.7M -52.78% | 175.0M +12.29% | |
Total Current Assets | 55.0M -32.77% | 81.9M -2.43% | 83.9M -53.64% | 181.0M -5.68% | |
Accumulated Depreciation | 1.8M +26.91% | 1.5M N/A | 0 -100.00% | 6.2M +6.67% | |
Property and Plant and Equipment and Net | 979,000 -28.54% | 1.4M N/A | 0 -100.00% | 1.1M -52.13% | |
Total Long-Term Assets | 0 -100.00% | 116,000 N/A | 0 -100.00% | 1.1M -52.13% | |
Total Assets | 61.8M -33.09% | 92.3M +9.19% | 84.6M -62.99% | 228.5M +7.91% | |
Income Taxes Payable | N/A N/A | 0 N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 6.2M +101.32% | 3.1M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 11.3M -31.09% | 16.5M +42.27% | 11.6M -48.74% | 22.6M +31.06% | |
Total Long-Term Debt | 3.5M -63.66% | 9.6M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 0 -100.00% | 55.0M N/A | 0 -100.00% | 27.9M +12.37% | |
Total Liabilities | 19.8M -77.20% | 86.7M +648.79% | 11.6M -77.08% | 50.5M +20.02% | |
Retained Earnings | -205.0M -12.70% | -234.8M -56.68% | -542.1M +26.32% | -429.1M +1.18% | |
Total Stockholders Equity | 42.0M +640.33% | 5.7M -92.23% | 73.0M -58.99% | 178.0M +4.91% | |
Total Shares Outstanding | 12.9M +5.41% | 12.2M -78.98% | 58.0M +0.93% | 57.5M +0.58% | |
Cash Flow | |||||
Cash from Operating Activities | -33.5M -50.46% | -67.7M -29.63% | -96.2M -15.34% | -113.7M +3.56% | |
Capital Expenditures | 0 -100.00% | 75,000 -67.11% | 228,000 -82.26% | 1.3M -46.37% | |
Cash from Investing Activities | 7.0M -64.87% | 19.9M -80.34% | 101.3M +175.97% | 36.7M +172.29% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -3.1M -103.28% | 95.1M +51,605.43% | 184,000 -69.13% | 596,000 -98.86% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | 31.45% N/A | N/A N/A | -8,774.13% +111.19% | -4,154.64% +1,370.96% | |
Return on Assets | 38.70% +171.71% | -53.97% -25.22% | -72.17% +3,073.78% | -2.27% -94.35% | |
Return on Equity | 125.06% +203.06% | -121.36% +34.81% | -90.02% +3,026.23% | -2.88% -94.50% | |
Revenue Growth | N/A N/A | -100.00% +56.34% | -63.97% -29.36% | -90.56% -107.83% | |
Current Ratio | 4.85 -2.43% | 4.97 -31.42% | 7.25 -9.57% | 8.02 -28.03% | |
Cash Ratio | 4.26 -10.11% | 4.74 +39.56% | 3.39 +125.38% | 1.51 -76.07% | |
Debt-to-Equity Ratio | 0.23 -89.63% | 2.23 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.16 +14.67% | 0.14 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow